CCNF is a potential pancancer biomarker and immunotherapy target
BackgroundCCNF catalyzes the transfer of ubiquitin molecules from E2 ubiquitin-conjugating enzymes to target proteins, thereby regulating the G1/S or G2/M transition of tumor cells. Thus far, CCNF expression and its potential as a pancancer biomarker and immunotherapy target have not been reported.M...
Main Authors: | Lifang Wei, Huiming Li, Mengjun Xiao, Cuiling Zhou, Jiliang Liu, Shilian Weng, Ruda Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1109378/full |
Similar Items
-
Does the LHPP gene share a common biological function in pancancer progression?
by: Kai Guo, et al.
Published: (2022-11-01) -
Screening for CCNF Mutations in a Chinese Amyotrophic Lateral Sclerosis Cohort
by: Danyang Tian, et al.
Published: (2018-06-01) -
Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)
by: Changwu Wu, et al.
Published: (2021-07-01) -
ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
by: Lingyi Zhou, et al.
Published: (2022-05-01) -
Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
by: Ye Xiong, et al.
Published: (2022-09-01)